Leukemia Research
Volume 29, Issue 7 , Pages 729-734 , July 2005

Lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia derives from an extensively hypermutated B cell that lacks ongoing somatic hypermutation

  • Sarah H. Walsh

      Affiliations

    • Department of Genetics and Pathology, Rudbeck Laboratory, Uppsala University, SE-75185 Uppsala, Sweden
    • ,
  • Anna Laurell

      Affiliations

    • Department of Oncology, Radiology, and Clinical Immunology, Uppsala University, Uppsala, Sweden
    • ,
  • Gunnel Sundström

      Affiliations

    • Department of Internal Medicine, Section of Haematology, Norrlands University Hospital, Umeå, Sweden
    • ,
  • Göran Roos

      Affiliations

    • Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden
    • ,
  • Christer Sundström

      Affiliations

    • Department of Genetics and Pathology, Rudbeck Laboratory, Uppsala University, SE-75185 Uppsala, Sweden
    • ,
  • Richard Rosenquist

      Affiliations

    • Department of Genetics and Pathology, Rudbeck Laboratory, Uppsala University, SE-75185 Uppsala, Sweden
    • Corresponding Author InformationCorresponding author. Tel.: +46 18 6115947; fax: +46 18 554025.

Received 6 September 2004 ,Accepted 17 December 2004.

References 

  1. Stansfeld AG, Diebold J, Noel H, et al. Updated Kiel classification for lymphomas. Lancet. 1988;1(8580):292–293
  2. Harris NL, Jaffe ES, Stein H, et al. A revised European–American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84(5):1361–1392[see comments]
  3. In:  Jaffe ES,  Harris NL,  Stein H, et al. editor. World health organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001;
  4. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood 1997;89(11): 3909–18.
  5. Owen RG, Treon SP, Al-Katib A, et al. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. Semin Oncol. 2003;30(2):110–115
  6. Sahota SS, Garand R, Bataille R, et al. VH gene analysis of clonally related IgM and IgG from human lymphoplasmacytoid B-cell tumors with chronic lymphocytic leukemia features and high serum monoclonal IgG. Blood. 1998;91(1):238–243
  7. Papamichael D, NKorton AJ, Foran JM, et al. Immunocytoma: a retrospective analysis from St Bartholomew's Hospital, 1972 to 1996. J Clin Oncol. 1999;17(9):2847–2853
  8. Sahota SS, Forconi F, Ottensmeier CH, et al. Typical Waldenstrom macroglobulinemia is derived from a B-cell arrested after cessation of somatic mutation but prior to isotype switch events. Blood. 2002;100(4):1505–1507
  9. Kriangkum J, Taylor BJ, Treon SP, et al. Clonotypic IgH VDJ sequence analysis in Waldenstrom's macroglobulinemia suggests an unusual B cell origin and expansion of polyclonal B cells in peripheral blood. Blood. 2004;
  10. Aoki H, Takishita M, Kosaka M, et al. Frequent somatic mutations in D and/or JH segments of Ig gene in Waldenstrom's macroglobulinemia and chronic lymphocytic leukemia (CLL) with Richter's syndrome but not in common CLL. Blood. 1995;85(7):1913–1919
  11. Ciric B, VanKeulen V, Rodriguez M, et al. Clonal evolution in Waldenstrom macroglobulinemia highlights functional role of B-cell receptor. Blood. 2001;97(1):321–323
  12. Kuppers R, Zhao M, Rajewsky K, et al. Detection of clonal B cell populations in paraffin-embedded tissues by polymerase chain reaction. Am J Pathol. 1993;143(1):230–239
  13. Thorselius M, Walsh S, Eriksson I, et al. Somatic hypermutation and V(H) gene usage in mantle cell lymphoma. Eur J Haematol. 2002;68(4):217–224
  14. Walsh SH, Thorselius M, Johnson A, et al. Mutated VH genes and preferential VH3-21 use define new subsets of mantle cell lymphoma. Blood. 2003;101(10):4047–4054
  15. Lefranc MP, Giudicelli V, Ginestoux C, et al. IMGT: the international ImMunoGeneTics database. Nucleic Acids Res. 1999;27(1):209–212
  16. Shiokawa S, Suehiro Y, Uike N, et al. Sequence and expression analyses of mu and delta transcripts in patients with Waldenstrom's macroglobulinemia. Am J Hematol. 2001;68(3):139–143
  17. Deane M, Baker BW, Norton JD. Immunoglobulin VH4 gene usage in B lymphoid leukaemias. Br J Haematol. 1993;84(2):242–249
  18. Efremov DG, Ivanovski M, Siljanovski N, et al. Restricted immunoglobulin VH region repertoire in chronic lymphocytic leukemia patients with autoimmune hemolytic anemia. Blood. 1996;87(9):3869–3876
  19. Ivanovski M, Silvestri F, Pozzato G, et al. Somatic hypermutation, clonal diversity, and preferential expression of the VH 51p1/VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas. Blood. 1998;91(7):2433–2442
  20. Fais F, Ghiotto F, Hashimoto S, et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest. 1998;102(8):1515–1525
  21. Tobin G, Thunberg U, Johnson A, et al. Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia. Blood. 2002;99(6):2262–2264
  22. Lin P, Mansoor A, Bueso-Ramos C, et al. Diffuse large B-cell lymphoma occurring in patients with lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia. Clinicopathologic features of 12 cases. Am J Clin Pathol. 2003;120(2):246–253

PII: S0145-2126(05)00035-4

doi: 10.1016/j.leukres.2004.12.008

Leukemia Research
Volume 29, Issue 7 , Pages 729-734 , July 2005

Article Tools